16 days ago
RAPP
AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Top 12%
#629 out of 5290 analysts
Average Return
+13.99%
Win Rate
47%49 out of 104
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +1,074.35% | $5.42 | $63.65 | 2024-10-09 - 2025-10-09 | Buy |
Palvella Therapeutics IncPVLA | +272.32% | $31.00 | $115.42 | 2025-07-20 - 2026-06-03 | Strong Buy |
Sage Therapeutics IncSAGE | +149.76% | $70.20 | $175.33 | 2017-05-15 - 2018-05-16 | Buy |
Centessa Pharmaceuticals PLCCNTA | +148.13% | $16.06 | $39.85 | 2025-07-20 - 2026-06-03 | Strong Buy |
Dianthus Therapeutics IncDNTH | +139.05% | $35.55 | $84.97 | 2025-10-13 - 2026-06-03 | Strong Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
22 days ago
PRAX
a month ago
NBIX
a month ago
BBIO
3 months ago
DNTH
3 months ago
BBIO
4 months ago
NBIX
4 months ago
CNTA
5 months ago
ARGX
5 months ago
NBIX
5 months ago
DNTH
5 months ago
CNTA
5 months ago
BBIO
6 months ago
PVLA
7 months ago
IRON
7 months ago
BBIO
8 months ago
ALNY
8 months ago
PVLA
2 years ago
SRPT
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $616.00 | +120.84% | Maintains | 2 days ago |
Apogee Therapeutics IncAPGE | 2 | Hold | $81.00 | -3.79% | Maintains | 8 days ago |
Immunovant IncIMVT | 7 | Hold | $30.00 | -3.69% | Maintains | 13 days ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $56.00 | +51.35% | Assumes | 16 days ago |
Insmed IncINSM | 1 | Strong Buy | $185.00 | +78.12% | Maintains | 21 days ago |
Harmony Biosciences Holdings IncHRMY | 10 | Hold | $29.00 | -9.66% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 10 | Strong Buy | $155.00 | -6.12% | Maintains | a month ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $15.00 | +160.42% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $102.00 | +55.77% | Maintains | a month ago |
Maze Therapeutics IncMAZE | 2 | Strong Buy | $64.00 | +157.44% | Maintains | 2 months ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $505.00 | +72.60% | Maintains | 2 months ago |
Climb Bio IncCLYM | 1 | Strong Buy | $17.00 | +62.84% | Initiates Coverage On | 3 months ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $110.00 | +29.46% | Maintains | 3 months ago |
Disc Medicine IncIRON | 7 | Strong Buy | $83.00 | +17.98% | Maintains | 3 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $38.00 | -4.64% | Maintains | 4 months ago |
Argenx SeARGX | 8 | Strong Buy | $1,030.00 | +26.67% | Maintains | 5 months ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $60.00 | +111.12% | Maintains | 5 months ago |
Palvella Therapeutics IncPVLA | 4 | Strong Buy | $190.00 | +64.62% | Maintains | 6 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $47.00 | +515.99% | Initiates Coverage On | 8 months ago |
Jefferson Capital IncJCAP | 1 | Strong Buy | $24.00 | +54.64% | Initiates Coverage On | 10 months ago |
Uniqure NvQURE | 6 | Strong Buy | $52.00 | N/A | Upgrades | a year ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $79.00 | N/A | Reinstates | 2 years ago |
Regenxbio IncRGNX | 1 | Buy | $18.00 | N/A | Reinstates | 2 years ago |
Sarepta Therapeutics IncSRPT | 2 | Buy | $150.00 | N/A | Reinstates | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $50.00 | N/A | Reinstates | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $51.00 | N/A | Reinstates | 2 years ago |
Biogen IncBIIB | 1 | Buy | $283.00 | N/A | Upgrades | 2 years ago |
Passage Bio IncPASG | 5 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Ptc Therapeutics IncPTCT | 6 | Buy | $55.00 | N/A | Maintains | 3 years ago |
Kyntra Bio IncKYNB | 2 | Buy | $875.00 | N/A | Upgrades | 3 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $35.00 | N/A | Downgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 5 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 8 years ago |
Sage Therapeutics IncSAGE | 1 | Buy | $82.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.